1. Home
  2. EXFY vs ENTA Comparison

EXFY vs ENTA Comparison

Compare EXFY & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXFY
  • ENTA
  • Stock Information
  • Founded
  • EXFY 2008
  • ENTA 1995
  • Country
  • EXFY United States
  • ENTA United States
  • Employees
  • EXFY N/A
  • ENTA N/A
  • Industry
  • EXFY Computer Software: Prepackaged Software
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXFY Technology
  • ENTA Health Care
  • Exchange
  • EXFY Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • EXFY 165.4M
  • ENTA 164.6M
  • IPO Year
  • EXFY 2021
  • ENTA 2013
  • Fundamental
  • Price
  • EXFY $1.93
  • ENTA $8.72
  • Analyst Decision
  • EXFY Strong Buy
  • ENTA Strong Buy
  • Analyst Count
  • EXFY 3
  • ENTA 4
  • Target Price
  • EXFY $4.75
  • ENTA $22.25
  • AVG Volume (30 Days)
  • EXFY 712.0K
  • ENTA 164.5K
  • Earning Date
  • EXFY 11-06-2025
  • ENTA 08-11-2025
  • Dividend Yield
  • EXFY N/A
  • ENTA N/A
  • EPS Growth
  • EXFY N/A
  • ENTA N/A
  • EPS
  • EXFY N/A
  • ENTA N/A
  • Revenue
  • EXFY $144,251,000.00
  • ENTA $64,806,000.00
  • Revenue This Year
  • EXFY $5.45
  • ENTA N/A
  • Revenue Next Year
  • EXFY $2.56
  • ENTA $1.65
  • P/E Ratio
  • EXFY N/A
  • ENTA N/A
  • Revenue Growth
  • EXFY 4.13
  • ENTA N/A
  • 52 Week Low
  • EXFY $1.60
  • ENTA $4.09
  • 52 Week High
  • EXFY $4.13
  • ENTA $13.37
  • Technical
  • Relative Strength Index (RSI)
  • EXFY 47.58
  • ENTA 58.78
  • Support Level
  • EXFY $1.88
  • ENTA $8.50
  • Resistance Level
  • EXFY $1.97
  • ENTA $9.08
  • Average True Range (ATR)
  • EXFY 0.07
  • ENTA 0.43
  • MACD
  • EXFY 0.03
  • ENTA 0.01
  • Stochastic Oscillator
  • EXFY 58.11
  • ENTA 59.42

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: